Stevens Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-8,919
| Closed | -$382K | – | 4 |
|
|
2019
Q4 | $382K | Buy |
+8,919
| New | +$382K | 0.04% | 398 |
|
|
2018
Q4 | – | Sell |
-57,727
| Closed | -$1.2M | – | 672 |
|
|
2018
Q3 | $1.2M | Sell |
57,727
-5,169
| -8% | -$107K | 0.04% | 399 |
|
|
2018
Q2 | $960K | Buy |
62,896
+1,577
| +3% | +$24.1K | 0.03% | 438 |
|
|
2018
Q1 | $1.38M | Buy |
61,319
+2,802
| +5% | +$63K | 0.05% | 357 |
|
|
2017
Q4 | $1.76M | Buy |
+58,517
| New | +$1.76M | 0.07% | 318 |
|
|
2017
Q1 | – | Sell |
-36,171
| Closed | -$1.04M | – | 844 |
|
|
2016
Q4 | $1.04M | Sell |
36,171
-20,978
| -37% | -$605K | 0.04% | 424 |
|
|
2016
Q3 | $1.82M | Buy |
+57,149
| New | +$1.82M | 0.08% | 300 |
|
|
2014
Q3 | – | Sell |
-11,199
| Closed | -$253K | – | 966 |
|
|
2014
Q2 | $253K | Buy |
+11,199
| New | +$253K | 0.01% | 865 |
|